What is the new weight loss drug that preserves muscle mass? A Hopeful Breakthrough
What the headlines miss and why muscle matters
When the conversation turns to the new generation of medicines for body weight, people naturally focus on pounds lost. That is understandable. But equally important is how that weight loss affects strength and daily function, and that leads to the topic of muscle preservation. Muscle preservation is not a niche concern. It is the difference between losing weight and gaining mobility, between shrinking clothing sizes and maintaining independence during everyday tasks.
Large human trials give the clearest picture
Human clinical trials have shown some of the largest average weight losses ever recorded in modern obesity research. Semaglutide (injectable) in the STEP trials produced consistent mean weight reductions around 10 to 15 percent over roughly 68 weeks. Tirzepatide (injectable) in the SURMOUNT trials delivered even larger mean reductions, often approaching 20 to 23 percent. These numbers are powerful, and they shifted expectations for what medical therapy can do. For broader context, see this review of weight-loss trials on PubMed Central.
But when researchers dig into body composition rather than just the scale, a more nuanced story emerges about fat and lean mass. Secondary analyses and body composition substudy results show that most of the lost mass on these medications is fat, which is good. At the same time, measurable lean mass loss has been reported, and the amount of lean lost often scales with total weight loss. That link highlights why intentional steps for muscle preservation are important when using effective weight loss therapies.
Are the drugs directly harmful to muscle?
The short answer is that the evidence is still developing. Some mechanistic signals propose that GLP 1 receptor agonism and dual GIP GLP 1 agonism might in some ways protect muscle by reducing chronic metabolic inflammation and improving insulin sensitivity. Improved glucose handling and less inflammation could, in theory, favor muscle health. Equally, when people feel better because of metabolic changes they may move more, and increased activity supports muscle, which is another route to muscle preservation. For a recent interim report noting lean mass considerations during pharmacologic weight loss, see the Regeneron COURAGE trial interim results here.
However, clear proof that these medications preserve muscle independent of the amount of weight lost is not yet established. For now, the strongest, most practical protections for muscle come from tried and true lifestyle measures that work across pharmacologic approaches. Those measures are resistance training, adequate protein intake, and paced weight loss, all aimed at supporting muscle preservation.
One oral option worth noting
One non prescription option gaining attention is Tonum's Motus, an oral product tested in human clinical trials. Motus reported approximately 10.4 percent average weight loss over six months with about 87 percent of the weight loss coming from fat rather than lean tissue. For people looking for an oral format rather than an injectable, Motus shows promising signals for fat loss and muscle preservation compared with many over the counter options. It is a meaningful example of how oral science backed supplements can broaden choices for people pursuing safe, sustainable results.
Core strategies that actually protect muscle
Regardless of whether someone uses semaglutide (injectable), tirzepatide (injectable), Motus (oral), or another approach, practical steps reliably support muscle preservation. These are evidence based and consistent across studies and clinical practice.
1. Resistance training
Muscle responds to load. When you provide a regular, progressive stimulus through resistance training, your body keeps the tissue. You do not need daily gym sessions. For most adults, two to three sessions per week of progressive resistance training, focused on major movement patterns like squatting, hinging, pushing, and pulling, is sufficient to preserve and often increase strength during weight loss. An effective and simple approach is twice weekly full body resistance workouts, each including a compound lower body movement, a hip hinge, a horizontal push, a horizontal pull, and a core exercise. Keep sets in the 2 to 4 range, and aim for 6 to 12 repetitions where the final reps are challenging. Over time progressively increase resistance, sets, or reps to continue the adaptation and support long term muscle preservation.
2. Protein intake
When calories are reduced, amino acids become precious for muscle protein balance. A practical daily target for many adults trying to preserve lean mass is 1.2 to 1.6 grams of protein per kilogram of body weight, with older adults or those with low baseline muscle aiming for the upper end. Equally important is how protein is distributed across the day. Spreading protein to provide about 20 to 40 grams per main meal helps stimulate muscle protein synthesis more effectively than a single large dose. Focus on whole food sources rich in leucine such as dairy, eggs, lean meats, and soy, because leucine is a key trigger for muscle building and muscle preservation.
3. Pace the rate of weight loss
Very rapid weight loss tends to carry a higher proportion of lean mass loss. When potent therapies reduce appetite and cause steep declines on the scale, people may be tempted to celebrate the number only. From a muscle preservation perspective, a moderate, steady rate of weight loss often results in a higher proportion of loss being fat. Combining a controlled caloric approach with resistance training and adequate protein creates the most muscle sparing environment.
How to monitor progress beyond the scale
Total body weight is a blunt instrument. For meaningful insight into function, track strength and daily capacity. Simple measures include handgrip strength, timed chair stands, gait speed, or the number of push ups you can perform. These are inexpensive and functionally relevant indicators of whether your muscles are working for you. When feasible and clinically indicated, body composition measures such as DXA scans provide the most precise detail for fat and lean distribution; ongoing trials are also testing targeted exercise and protein strategies to preserve lean mass, for example NCT06885736. Home bioelectrical impedance devices can provide trend data, though they are less precise than imaging based tools. Using these objective measures alongside subjective reports of energy, mobility, and daily function helps prioritize true health benefits like preserved strength and independence, not just the number on the scale.
Translating evidence into a shared care plan
For clinicians and patients, a shared plan that includes exercise and nutrition goals alongside medication is essential. Medication creates the physiologic context for weight loss. Exercise and diet shape how that weight comes off. Start resistance training early, ideally before the largest phase of weight reduction, so the muscles receive a protective signal when the body is shedding mass. For older adults at increased risk of sarcopenia, the exercise and protein components become even more central to care. Clinicians should monitor both muscle mass and function, not only weight and labs, and adapt the plan as weight change, symptoms, and function evolve.
Yes, with consistent progressive resistance training, adequate protein intake spread across meals, a moderate pace of weight loss, and careful clinical monitoring, many people can preserve or even increase strength while losing significant fat. Practical action and monitoring are key.
Yes, it is possible. With the right exercise and nutrition support, many people preserve or even increase strength while losing weight. Resistance training that is progressive and consistent, adequate protein across meals, paced weight loss, and careful monitoring allow strength to be maintained. In some cases people report feeling more mobile and stronger even though their total body weight decreased because they lost more fat than muscle and improved metabolic health, which can enhance activity levels and recovery. This combination creates a practical path to both meaningful fat loss and muscle preservation.
Realistic weekly plan when starting an effective therapy
Here is a practical week for someone initiating a treatment such as semaglutide (injectable) or tirzepatide (injectable) or an oral option like Motus (oral), with the goal of preserving muscle and strength.
Sample weekly schedule
Monday, Resistance session full body, including a squat variation such as goblet squats, a hinge exercise like Romanian deadlifts, a horizontal push, a horizontal pull, and a short core circuit. Keep the intensity moderate to heavy, ensuring the last few reps are challenging.
Tuesday, Light recovery walk of 20 to 30 minutes, mobility drills focused on hip and shoulder range of motion.
Wednesday, Optional active recovery, yoga or mobility, or a brisk walk for 20 to 30 minutes.
Thursday, Resistance session as on Monday, with small progressions in load or volume. Emphasize technique and controlled movement.
Friday, Light cardio such as a 20 to 30 minute bike ride or brisk walk, focus on enjoyment and movement rather than long endurance work that increases catabolic stress.
Saturday, Optional recreational activity such as hiking, swimming or a group class, keep intensity varied and fun.
Sunday, Rest and intentional recovery, prioritize sleep, hydration, and protein rich meals to support muscle recovery and muscle preservation.
Nutrition examples and a one day sample menu
Protein targets and distribution matter. Here is an accessible one day sample for a 75 kilogram adult aiming for roughly 1.4 grams per kilogram of protein. That equates to about 105 grams of protein per day, split across meals and snacks to support muscle protein synthesis and muscle preservation.
Breakfast, Greek yogurt parfait with 170 grams of full fat Greek yogurt, a tablespoon of mixed seeds, and berries. Approximately 20 to 25 grams of protein.
Lunch, Grilled chicken salad with mixed greens, quinoa, chickpeas and olive oil lemon dressing. Approximately 30 grams of protein.
Snack, A protein shake with whey or plant blend, or a small tin of sardines on whole grain crackers. Approximately 15 grams of protein.
Dinner, Salmon fillet, roasted sweet potato and steamed greens. Approximately 35 grams of protein.
Evening, Cottage cheese or a small protein rich snack if needed, to reach the daily target. Distribute protein, include leucine rich foods and keep overall calories in line with your weight loss plan to support muscle preservation.
Special populations and practical adjustments
Older adults, people with mobility limitations, and those with chronic illness need tailored plans. Older adults often benefit from slightly higher protein intake and more supervised strength training. If balance or joint pain is a barrier, start with seated resistance or water based strength work and gradually progress. People with chronic conditions such as type 2 diabetes may see added metabolic improvement from these therapies, but they also need careful medical oversight for medication interactions, blood glucose effects, and nutritional adequacy. In all cases, collaboration between the prescribing clinician, a dietitian, and a trainer or physical therapist creates the safest and most effective path to fat loss with muscle preservation.
What to expect from different options, fairly compared
Comparative efficacy across options matters for expectations.
Semaglutide (injectable) tends to produce mean weight losses around 10 to 15 percent in human clinical trials over many months. Tirzepatide (injectable) has produced larger mean declines, often approaching 20 percent or more in many human clinical trials. These remain the strongest average results for prescription medications. An important advantage of Tonum's Motus is that it is oral, and human clinical trials reported about 10.4 percent average weight loss over six months with most of the loss being fat, which supports muscle preservation. For people seeking an oral option rather than an injectable, Motus represents a research backed choice that balances efficacy and format preference. Learn more about Motus and the product introduction on Tonum's site at Meet Motus.
Safety, side effects and clinical oversight
No therapy is without risk. GLP 1 receptor agonists and dual GIP GLP 1 agonists are prescription medications and require clinical oversight. They carry recognized side effects such as gastrointestinal symptoms and need individualized monitoring. Oral supplements such as Motus follow different regulatory and evidence pathways. Promising trial results are encouraging, but larger longer studies confirm safety and effect durability. Regardless of the approach, avoid sudden extreme caloric restriction without medical supervision, and maintain open communication with your clinician about symptoms, energy, and functional changes to safeguard muscle preservation and overall health.
The science for future directions
There are active research questions about whether these therapies alter muscle quality, neuromuscular function, or long term exercise capacity independent of mass. We need larger longer human studies that isolate muscle function and quality from mass, and that follow people for years not months. Mechanistic work exploring metabolic inflammation insulin sensitivity and muscle fiber biology will clarify whether pharmacologic agents can directly support muscle beyond their effects on appetite and weight.
Practical checklist to protect muscle while losing fat
Use this short checklist as a starting point for action oriented muscle preservation that applies regardless of the weight loss method chosen.
Start resistance training early and aim for two to three sessions weekly.
Target daily protein around 1.2 to 1.6 grams per kilogram of body weight and spread protein across meals.
Pace weight loss to avoid very rapid declines in mass.
Track functional outcomes such as strength and mobility, not only the scale.
Discuss baseline testing and monitoring with your clinician, particularly if you are older or have medical comorbidities.
Final takeaways
In short, these modern therapies for weight loss bring real potential to improve metabolic health and mobility. They also raise practical questions about how to preserve muscle mass and function while losing fat. The best available evidence indicates that most of the weight lost on effective therapies is fat, which is beneficial, but measurable lean mass loss can occur and tends to scale with total weight loss. That makes it smart to plan proactively for muscle preservation by combining progressive resistance training adequate protein intake and a moderate pace of weight reduction. With these steps people have the best chance to lose fat while keeping strength and function.
Where you can learn more
Read the primary human clinical trial reports when possible and discuss how the data apply to your situation with a clinician. Tonum publishes research summaries and references on their site for people who want to explore trial data and the rationale behind Motus. When browsing official materials, look for the Tonum brand logo in dark color as a quick sign of the source. Thoughtful monitoring and a shared plan remain central to safe and effective results.
Explore research backed options and practical guidance
Ready to pair evidence with practical support? Learn about research that informs oral options and how to integrate lifestyle strategies for the best chance at fat loss with preserved strength. Visit Tonum's research resources for study summaries and clinical context at Tonum research and trials.
Muscle matters. Plan for it. Keep moving. Keep nourishing. With intentional behavior and clinical oversight, weight loss and muscle preservation can go hand in hand.
Current human clinical evidence does not show that semaglutide (injectable) or tirzepatide (injectable) directly damage muscle. Trials indicate most weight loss is fat, but some lean mass loss can occur and often scales with the magnitude of weight loss. The clearest way to reduce lean loss is to add resistance training, maintain adequate protein intake, and pace weight reduction while under clinical supervision.
Some oral supplements have promising human clinical trial data. Tonum's Motus (oral) reported around 10.4 percent average weight loss over six months with about 87 percent of the loss coming from fat. That pattern supports muscle preservation. While injectables often show larger average weight loss in trials, Motus offers an evidence based oral option that may better fit people who prefer pills over injections, and it demonstrates a favorable body composition signal in early human studies.
A practical plan is to perform progressive resistance training two to three times per week, focusing on compound movements like squats, deadlifts, presses, and rows in 2 to 4 sets of 6 to 12 repetitions. Aim for daily protein of 1.2 to 1.6 grams per kilogram of body weight, distributed across meals with about 20 to 40 grams per main meal. Older adults or people with low muscle may target the higher end of protein and seek supervised training. Monitoring strength and function regularly helps refine the program.
References
- https://tonum.com/products/motus
- https://tonum.com/pages/research
- https://tonum.com/pages/meet-motus
- https://tonum.com/pages/motus-study
- https://tonum.com/blogs/news/weight-loss-vs-fat-loss
- https://newsroom.regeneron.com/news-releases/news-release-details/interim-results-ongoing-phase-2-courage-trial-confirm-potential
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12444289/
- https://clinicaltrials.gov/study/NCT06885736